A single orally dissolving tablet increased likelihood of relief within 2 hours.

A small study pioneers a modified external reduction method.

Negative consequences appear at age 6 months.

Phase 3 trial finds drug cut number of weekly attacks by 3.5.

The findings of this new population-based study warrant caution in the use of NSAIDs in older patients.

A quarter of patients with cluster headaches could benefit from the device.

Pain intensity was greater for both VATS and open procedures.

Results of a phase 3 trial.

Approach can help reduce risk for addiction.

Especially recent and/or large prescriptions.

Prioritising alternative pain treatments in these groups could reduce misuse risks.

Little is known about the prevalence and effect of pain in adults with AD.

The impact of prescribing restrictions introduced in April 2018.

Nearly half of opioid-naive patients received opioids during their hospital stay.